Skip to main content

New Horizons Substance Use Recovery Network

Summary 
  • Need: In northern Michigan, a need for an integrated approach to deliver medication-assisted treatment for established patients of Federally Qualified Health Centers with opioid use disorder.
  • Intervention: Collaboration between one FQHC across 3 sites, a local waivered prescriber group, and a behavioral health organization created an integrated treatment approach for opioid use disorder.
  • Results: Increased access to medication-assisted treatment and comprehensive substance use disorder services leading to increased retention in treatment and increased engagement in stable recovery from opioid and alcohol use disorders.

Description

New Horizons Recovery Network According to Michigan's Department of Health and Human Services, from 1999 to 2016 total opioid overdose deaths increased from 99 to 1,699, a 17-fold increase. Additional data from Michigan's Automated Prescription System (MAPS) demonstrated 11.4 million prescriptions for painkillers in 2015 were written, or about 115 opioid prescriptions per 100 people. Public health efforts dealing with this situation involve a framework of prevention, treatment, and recovery. According to the Substance Abuse and Mental Health Service Administration (SAMHSA), medication-assisted treatment, or MAT, is a well-vetted integrated treatment for opioid use disorder (OUD) using medications in addition to counseling.

The program's three partners are Alcona Health Center, the FQHC; Freedom Recovery Center, the waivered provider group; and Catholic Human Services, Inc., the behavioral health group. Their goal is providing established FQHC patients with all of their medication-assisted treatment needs within the FQHC itself. After an in-house medical provider referral, patients undergo an intake assessment performed by the program's clinic-based nursing care coordinator. The care coordinator also arranges appointments with the on-site Freedom Recovery Center consultants who have the required training for prescribing MAT medications. The referral process also includes appointing with on-site Catholic Human Services team members for the behavioral health counseling that is part of the whole-patient OUD treatment.

The program is also designed to accommodate more urgent needs if patients are actively withdrawing from opioids, other substances, or having urgent mental health needs.

Prompted by the Centers for Disease Prevention and Control (CDC) reports of high per capita rates opioid overdoses and high prevalence of addiction-related infectious disease in area this program serves, Michigan Medicaid implemented a waiver program in the state's region the 3 partners serve. The program, called the Opioid Health Home, uses a hub and spoke referral model similar to that used in Vermont and accomplishes two objectives: increases access to OUD treatment for Medicaid patients and allows care coordination- and case management-like services to be billed.

The program's initial funding came through a 2015-2017 HRSA/SAMHSA grant awarded to the FQHC in order to expand MAT for substance use disorders, with special attention for OUD. Revenue generated from services performed within the program is early signs of service sustainability.

Services offered

  • Level one substance use treatment (Based on American Society of Addiction Medicine's Substance Use Disorder Treatment)
  • Individualized treatment plans which include general medical needs, medications for opioid use disorder, and counseling needs
  • Nursing care coordinator providing both intake care processing and ongoing care coordination
  • Five (increased from the initial 2) licensed master's level behavioral health clinicians/addiction counselors for the behavioral health portion of MAT
  • Five (increased from the initial 3) rotating MAT medication prescribers
  • Multidisciplinary team meetings every two weeks to review individual treatment plans, adjusting care when needed
  • "Curbside, warm handoff referrals" in addition to formal referral process
  • Urgent consultation to manage active withdrawal symptoms or urgent behavioral health needs
  • Coordinated referral to outside psychiatric services when needed
  • Coordinated referral to the Local Coordinating Agency, Michigan's state-funded entity that assists with residential treatment or detoxification programs when needed
    • (Note: Participants with opioid use disorder may also have co-existing alcohol use disorder or benzodiazepine use disorder. Though opioid withdrawal is extremely uncomfortable, in contrast, alcohol or benzodiazepine withdrawal are both life-threatening conditions which require a higher level of substance use treatment.)
  • Coordination with recovery program transitions
  • Integration with community services providing the additional social determinants of health interventions (for example, economics, education, employment, housing)

Results

From the initial grant cycle, data from patients enrolled May 2016 through final report:

  • Current caseload:
    • 32% of patients have been in the program for 18 months or more
    • Many patients stabilized on maintenance
    • 3 buprenorphine-treated pregnant patients had safe deliveries
    • Many patients have remained employed/found new employment
    • Some patients have returned to college or completed GED

Additional in-house observations:

  • Increased primary care provider referrals
  • Increased medical provider awareness of opioid addiction risks

Additional impact: community-collaborations

  • Program now linked with community partners; for example, collaboration with focus on a Family Recovery Team to impact parental rights terminations often associated with substance use disorders
  • Community integration with educational programs on issues leading to opioid and substance use disorders such as building capacity for addressing adverse traumatic events

Barriers

  • Initial buy-in from primary care providers
  • Workforce scarcity issues for recruitment and retention of qualified behavioral health and substance abuse treatment providers
  • Sustainability
  • With initial grant program, patient numbers precluded additional enrollees due to unanticipated high participant retention
  • Ensuring transition to local recovery services

Replication

To reproduce this program in other areas:

  • Acknowledge that identifying a common goal brings motivated partners to the planning table
  • Acknowledge medication-assisted treatment as an integrated treatment that must include overall medical care, counseling, and coordination with other agencies attending to the associated social determinants of health impacting the participants' overall quality of life

Contact Information

Dan Oliver, CMA, Substance Use Program Coordinator
Alcona Health Center - Alpena Services
989.358.3905
doliver@alconahc.org

Topics
Behavioral health
Illicit drug use
Prescription drug abuse
Substance abuse

States served
Michigan

Date added
March 15, 2018

Date updated or reviewed
July 24, 2019


Please contact the models and innovations contact directly for the most complete and current information about this program. Summaries of models and innovations are provided by RHIhub for your convenience. The programs described are not endorsed by RHIhub or by the Federal Office of Rural Health Policy. Each rural community should consider whether a particular project or approach is a good match for their community’s needs and capacity. While it is sometimes possible to adapt program components to match your resources, keep in mind that changes to the program design may impact results.